In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

The vacancy rate for Chicago’s life sciences sector was 40.5% as of the fourth quarter of 2024, with about 2M SF of total ...

As the industry looks to 2025, the health care and life sciences sectors are poised for growth, driven by groundbreaking ...

Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer. Read why OLMA stock is a Hold.

About two and a half years before they sealed a $3.3 billion deal, Bain Capital and its life sciences team started courting ...

Through this platform, Carlyle will help Roop and Highway leverage operating synergies, create capabilities and capacities ...

Bain Capital Credit, LP, a leading global credit specialist, today announced that the firm’s Private Credit Group invested $6 billion to support the growth of middle market and private equity-backed ...

We recently published a list of 11 AI News and Ratings on Investors’ Radar. In this article, we are going to take a look at ...

We recently published a list of 11 AI News and Ratings on Investors’ Radar. In this article, we are going to take a look at ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Fintel reports that on February 12, 2025, Keybanc initiated coverage of Rapid Micro Biosystems (NasdaqCM:RPID) with a ...